epithalon clinical trial Epitalon Peptide Epithalon Dosage Guide: How Much

BPC-157 is the synthetic form of a peptide sequence (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) found in mammalian gastric juice

Most protocols deliver 1 to 3 mg per day subcutaneously, either daily or 5 days on with 2 days off

This is why ex vivo findings need to be confirmed in human trials which subsequent studies like the 2016 GHK peptide clinical trial and the 2021 copper tripeptide serum trial have done

This nuclear presence of FOXO4 seems to be involved in maintaining the viability of senescent cells by possibly modulating downstream senescence-associated pathways, detailed by changes in p53, Ser15-phospho-p53, and p21 protein levels

All findings are limited to controlled cell based and preclinical settings and do not imply therapeutic use